Vista Therapeutics

Vista Therapeutics develops NW biosensor arrays and systems for multiplex biomarker measurement.

Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. The company focuses on developing NW biosensor arrays and systems, Vista-labeled sample preparation kits, continuous plasma separation devices, chip reading devices, cards and sensor readers, and nanowire chips. It serves markets, such as pharmacokinetic and toxicokinetic studies in animals, tissue culture applications, assessment of urinary markers, optimization of kidney dialysis, assessment and monitoring of acutely ill/injured patients, and optimization of treatment with highly toxic drugs. The company has strategic partnerships with MesoSystems/ICX and Tokyo Electron Limited. Vista Therapeutics, Inc. was founded in 2007 and is headquartered in Sante Fe, New Mexico. It has a facility in Cambridge, Massachusetts.